Milestones and
momentum

Completed ICURe (Innovation to Commercialisation of University Research) Round 1, Explore (April–December 2024), and Round 2, Exploit (June 2025–May 2026), together with a £300k grant, advancing the platform to Technology Readiness Level 8 (TRL8).

Established a radiopharmaceutical production partnership based in the Cambridge Biomedical Campus area, supporting UK-based, cassette-enabled manufacturing.